Overview:
Molecular profiling has fundamentally reshaped the management of non-small cell lung cancer (NSCLC), expanding the landscape of actionable biomarkers and generating a rapidly growing arsenal of targeted therapies with distinct mechanisms, efficacy profiles, and toxicity patterns. For oncology nurses, who serve as essential advocates across the full arc of patient care, this pace of therapeutic innovation creates a mounting imperative to remain current on evolving best practices.
This CE-certified hybrid satellite symposium brings
together a panel of expert faculty specializing in NSCLC management to address
these challenges through a combination of didactic presentations and case-based
discussions. Faculty will examine comprehensive biomarker testing before moving
through targeted therapy updates across key biomarker-driven subtypes, with a
focus on adverse event recognition and management strategies relevant to the
practicing nurse. Case conversations will give the audience critical pearls for
practice, supporting adherence on novel therapies, guiding clinical trial
conversations, and navigating the nuanced toxicity profiles of next-generation
agents.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Describe testing indications, key biomarkers, and the nursing role in comprehensive molecular testing for patients with NSCLC
- Apply best practices for adverse event prevention, monitoring, and intervention for patients with NSCLC receiving targeted therapy
- Implement strategies to explain biomarker testing, manage expectations with new therapies, and support shared decision-making for patients with NSCLC
Target Audience:
This educational activity is directed toward oncology
nurses, nurse practitioners, physicians and other advanced practice providers
who manage patients with NSCLC.
Benjamin P. Levy, MD
Associate Professor of Oncology
Johns Hopkins University School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Sibley Memorial Hospital
Washington, DC
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.
